JACN Did you know that you can get alerts when a new issue is online?
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
QUICK SEARCH:   [advanced]


     

This Article
Right arrow Figures Only
Right arrow Full Text
Right arrow Full Text (PDF)
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Turner, R. J.
Right arrow Articles by Vink, R.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Turner, R. J.
Right arrow Articles by Vink, R.
Journal of the American College of Nutrition, Vol. 23, No. 5, 541S-544S (2004)
Published by the American College of Nutrition

Magnesium Gluconate Offers No More Protection than Magnesium Sulphate Following Diffuse Traumatic Brain Injury in Rats

Renee J. Turner, BSc, K. W. DaSilva, C. O’Connor, Corinna van den Heuvel, PhD and Robert Vink, PhD

Department of Pathology, University of Adelaide, Adelaide SA, AUSTRALIA

Address reprint requests to: Robert Vink, Ph.D., Department of Pathology, University of Adelaide, Adelaide SA, AUSTRALIA. E-mail: robert.vink{at}adelaide.edu.au

Objective: Previous studies have demonstrated that magnesium salts, including the sulphate and chloride forms, are neuroprotective following traumatic brain injury (TBI). Recently, studies in cardiac ischaemia/reperfusion injury have demonstrated that the gluconate salt of magnesium may provide superior protection against oxidative damage and postischaemic dysfunction than MgSO4. We have therefore compared the efficacy of both MgSO4 and magnesium gluconate (MgGl2) on outcome following diffuse TBI in rats.

Methods: Adult male Sprague-Dawley rats were injured using the 2-metre impact acceleration model of diffuse TBI. At 30 min after injury, animals were administered with either 250µmoles/kg i.v. MgSO4, MgGl2, or equal volume saline vehicle. Thereafter, animals were assessed for motor and cognitive outcome using the rotarod and Barnes maze, respectively, or their brains removed at 3 days after TBI and used for histological examination.

Results: Treatment with either magnesium salt significantly improved functional outcome as compared to vehicle treated controls. Similarly, treatment with either magnesium salt attenuated the degree of histological dark cell change at 3 days after TBI relative to the vehicle treated animals. There were no significant differences between the magnesium treated groups.

Conclusions: We conclude that MgSO4 and MgGl2 are equally neuroprotective following TBI. Our results suggest that MgGl2 may only be more effective in conditions that produce ischaemia, where high concentrations of reactive oxygen species are generated.

Key words: magnesium salts, neuroprotection, traumatic brain injury, ischaemia, rat, reactive oxygen species






HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 2004 by the American College of Nutrition.